Researchers in the Murry Lab have demonstrated that a quadruple gene editing approach safely suppresses irregular heartbeats in stem cell therapy for injured hearts. Read More
Undergraduate student researchers Dessirée Ortaç and Eesha Murali have received Washington Research Foundation Fellowships that will support their time in the lab through the end of the 2023 school year. Read More
New data presented by ISCRM Director Chuck Murry suggests gene-editing may be the key to clearing a major hurdle for researchers hoping to remuscularize injured hearts with stem cell-derived cardiomyocytes Read More
ISCRM investigators use rainbow cell technology to demonstrate that injected heart cells proliferate, a finding that could help researchers enhance the efficacy of cell therapy for heart disease and other conditions. Read More
Nearly 18 million people die each year from heart disease, making it the leading cause of death in the world. In the United States alone, the economic impact of heart disease exceeds $200 billion, a figure that is expected to rise dramatically. Read More
In an exciting breakthrough that may have implications for stem cell-based treatment of heart disease, the lab of Dr. Deok-Ho Kim at the Institute for Stem Cell and Regenerative Medicine […] Read More